| Global Life Science ToolsLGCThe group has appointed Joydeep Goswami as President, Chief Executive Officer, and a member of the Board of Directors. He succeeds Euan O'Sullivan, who stepped down in early 2024 after 14 years with the company. Goswami served as Chief Financial Officer and Chief Strategy and Corporate Development Officer of Illumina from February 2023 and resigned in April 2024.Previously, he worked atThermo Fisher ScientificWith 16 years of work experience, holding various global and business unit leadership roles, ultimately leading Thermo Fisher's clinical next-generation sequencing and oncology division. Goswami also served at Biolife Solutions.(Nasdaq stock code:BLFS）He is a member of the board of directors. He holds a master's and Ph.D. in chemical engineering from MIT, an MBA degree, and a bachelor’s degree in chemical engineering from the Indian Institute of Technology Bombay.Joydeep has over 25 years of global experience with a strong background in life science tools, and a proven track record in formulating strategies and leading new product development, partnerships, licensing, and mergers and acquisitions. His experience as a P&L leader and CFO enables him to incorporate the perspectives of customers, employees, and investors into strategy formulation and resource allocation to drive robust profit growth. | 
